EU backs J&J COVID-19 vaccine despite blood clot risk
EU backs J&J COVID-19 vaccine despite blood clot risk The European Medicines Agency said its safety committee had concluded that a warning about unusual blood clots with low platelets must be added to the vaccine's labels, just as it has also required of rival vaccine maker AstraZeneca Reuters | April 20, 2021 | Updated 20:46 IST Representative Image Europe's drug regulator has found a possible link between Johnson & Johnson's COVID-19 vaccine and rare blood clotting issues in adults who received doses in the United States, but backed its overall benefits against any risks. The European Med...
Source: businesstoday.in